Human immune response to a plague vaccine comprising recombinant F1 and V antigens

Infection and Immunity

Volumn 73, Issue 6, 2005, Pages 3598-3608

  Williamson, E D ^a   Flick Smith, H C ^a   LeButt, C ^a   Rowland, C A ^a   Jones, S M ^a,b   Waters, E L ^a   Gwyther, R J ^a   Miller, J ^a   Packer, P J ^a   Irving, M ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b Public Health Agency of Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; EPITOPE; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; PLAGUE VACCINE; RECOMBINANT ANTIGEN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENICITY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PASSIVE IMMUNIZATION; PHASE 1 CLINICAL TRIAL; PLAGUE; PRIORITY JOURNAL; SEROLOGY; YERSINIA PESTIS;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; MALE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; VACCINES, SYNTHETIC;

EID: 21144478755     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.6.3598-3608.2005     Document Type: Article

References (32)

1. Anderson, G. W., S. E. C. Leary, E. D. Williamson, R. W. Titball S.L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Recombinant V antigen protects mice against pnuemonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64:4580-4585.
2. Andrews, G. P., D. G. Heath, G. W. Anderson, Jr., S. L. Welkos, and A. M. Friedlander. 1996. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:2180-2187.
3. Bartelloni, P. J., J. D. Marshall, Jr., and D. C. Cavanaugh. 1973. Clinical and serological responses to plague vaccine U.S.P. Mil. Med. 138:720-722.
4. Brekke, O. H., and I. Sandlie. 2003. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat. Rev. Drug Discovery 2:52-62.
5. Cavanaugh, D. C., B. L. Elisberg, C. H. Llewellyn, J. D. Marshall, J. H. Rust, J. E. Williams, and K. F. Meyer. 1974. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J. Infect. Dis. 129:S37-S40.
6. Green, M., D. Rogers, P. Russell, A. J. Stagg, D. L. Bell, S. M. Eley, R. W. Titball and E. D. Williamson. 1999. The SCID/beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23:107-113.
7. Heath, D. G., G. W. Anderson, J. M. Mauro, S. L. Welkos, G. P. Andrews, J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
8. Hill, J., S. E. C. Leary, K. F. Griffin, E. D. Williamson, and R. W. Titball. 1997. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun 65:4476-4482.
9. Janeway, C. A., Jr., P. Travers, M. Walport, and J. D. Capra. 1999. Immunobiology: the immune system in health and disease, 4th ed. Garland, London, England.
10. Jefferson, T., V. Demicheli, and M. Pratt. 2001. Vaccines for preventing plague (Cochrane Review). The Cochrane Library, vol. 4. Oxford University, Oxford, England.
11. Jones, S. M., F. Day, A. J. Stagg and E.D. Williamson. 2001. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine. 19:358-366.
12. Jones, S. M., K. F. Griffin, I. Hodgson, and E. D. Williamson. 2003. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine. 21:3912-3918.
13. Keeling, M. J., and C. A. Gilligan. 2000. Metapopulation dynamics of bubonic plague. Nature 407:903-906.
14. Leary, S. E. C., K. F. Griffin, H. S. Garmory., E. D. Williamson, and R. W. Titball. 1997. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb. Pathog. 23:167-179.
15. Marshall, J. D., P. J. Bartelloni, D. C. Cavanaugh, P. J. Kadull, and K. F. Meyer. 1974. Plague immunisation. II. Relation of adverse clinical reactions to multiple immunisations with killed vaccine. J. Infect. Dis. 129: S19-S25.
16. Marshall, J. D., D. C. Cavanaugh, P. J. Bartelloni, and K. F. Meyer. 1974. Plague immunization. III. Serologic response to multiple inoculations of vaccine. J. Infect. Dis. 129:S26-S29.
17. Meyer, K. F. 1953. Recent studies on the immunity response to administration of different plague vaccines. Bull. W.H.O. 9:619-636.
18. Meyer, K. F., D. C. Cavanaugh, P. J. Bartelloni, and J. D. Marshall. 1974. Plague immunization. I. Past and present trends. J. Infect. Dis. 129:S13-S18.
19. Meyer, K. F., G.Smith, L. E. Foster, J. D. Marshall, and D. C. Cavanaugh. 1974. Plague immunization. IV. Clinical reactions and serological responses to inoculations of Haffkine and freeze-dried plague vaccine. J. Infect. Dis. 129:S30-S36.
20. Meyer, K. F., J. A. Hightower, F. R. McCrumb. 1974. Plague immunization. VI. Vaccination with the fractionl antigen of Yersinia pestis. J. Infect. Dis. 129:S41-45.
21. Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
22. Reisman, R. E. 1970. Allergic reactions due to plague vaccine. J. Allergy 46:49-56.
23. Russell, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R.W. Titball. 1995. A comparison of plague USP and EV76 Vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551-1556.
24. Speck, R. S., and H. Wolochow. 1957. Studies on the experimental epidemiology of respiratory infections. VIII. Experimental pneumonic plague in Macacus rhesus. J. Infect. Dis. 100:58-69.
25. von Metz, E., D. M. Eisler, and G. A. Hottle. 1971. Immunogenicity of plague vaccines in mice and guinea pigs. Appl. Microbiol. 22:84-88.
26. Williams, J. E., P. L. Altieri, S. Berman, J. P. Lowenthaland, and D. C. Cavanaugh. 1980. Potency of killed plague vaccines prepared from avirulent Yersinia pestis. Bull. W.H.O. 58:753-756.
27. Williams, J. E., L. Arntzen, G. L. Tyndal, and M. Isaacson. 1986. Application of enzyme immunoassays for the confirmation of clinically suspect plague in Nambia, 1982. Bull World Health Organ 64:745-752.
28. Williamson, E. D., S. M. Eley, K. F. Griffin, M. Green, P. Russell, S. E. C. Leary, P. C. F. Oyston, T. Easterbrook, K. M. Reddin, A. Robinson, and R. W. Titball. 1995. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12:223-230.
29. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 1997. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunised animals against pneumonic plague. Vaccine 15:1079-1084.
30. Williamson, E. D., P. M. Vesey, K. J. Gillhespy, S. M. Eley, M. Green, and R. W. Titball. 1999. An IgG1 titer to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:107-114.
31. Williamson, E. D. 2001. Plague vaccine research and development J. Appl. Microbiol. 91:606-608.
32. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 2001. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19:566-571.